EUVIMEDEUVIMED entdecken
Crossref

Self-sacrificing templated-derived chitosan microcapsules for targeted drug delivery in thrombolytic therapy

Yanling Liang, Weikun Li, Xin Tan, Nuoya Chen, Diyi Feng, Yinghua Tao, Xiaojing Wu, Ling Liu, Liqin Ge

Journal of Controlled Release · 2026

DOI: 10.1016/j.jconrel.2026.114751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2026. Verfasst von Yanling Liang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, PR C…. Hauptthemen laut MEDLINE: Chitosan, Tissue Plasminogen Activator, Fibrinolytic Agents, Drug Delivery Systems. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Southeast University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thromboembolic diseases are a major global health threat. Yet current thrombolytic therapies remain limited by systemic off-target effects, short drug half-life, and poor thrombus penetrability. Herein, we report a self-sacrificing template strategy that enables simultaneous microcapsule assembly and template degradation, resulting in the formation of hollow chitosan microcapsules (CSMs) without the need for post-assembly template removal. The microcapsules obtained are then employed to cure thrombosis-related diseases. Using CaCO3 microparticles (CMPs) as templates, water-soluble chitosan (CS) is assembled onto porous CMP preloaded with recombinant tissue plasminogen activator (rt-PA) under controlled conditions, which triggers CMP dissolution while retaining rt-PA within the CSMs. Subsequently, CSMs are modified with fibrin-targeting CREKA peptides to produce rt-PA@CSMs-CREKA, which possess an optimal microscale size for overcoming margination effects. These microcapsules exhibit high drug loading, favorable biocompatibility, and prolonged circulation time. Both in vitro and in vivo studies demonstrate that rt-PA@CSMs-CREKA achieves superior thrombus targeting, site-specific drug accumulation, and enhanced penetration, effectively degrading fibrin networks and dissolving thrombotic clots. Compared with free rt-PA, rt-PA@CSMs-CREKA possesses significantly enhanced thrombolytic efficacy while downregulating key coagulation factors (FXa and PAI-1). This study presents a promising targeted delivery platform for thrombolytic therapy and offers a novel approach for fabricating CS-related polymeric microcapsules.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChitosanTissue Plasminogen ActivatorFibrinolytic AgentsDrug Delivery SystemsAnimalsCapsulesHumansThrombolytic TherapyThrombosisRecombinant Proteins

Stichwörter der Autor:innen

Drug deliveryMicrocapsuleTargeted thrombolysisVenous thrombosisWater-soluble chitosan

Substanzen

ChitosanTissue Plasminogen ActivatorCapsulesFibrinolytic AgentsRecombinant Proteins

Autor:innen und Institutionen

  • State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, PR China.
  • Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, PR China.
  • Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, PR China. Electronic address: liulingdoctor@…
  • State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, PR China; Advanced Ocean Institute of Southeast University, Nantong 226000…

Förderung

  • Southeast University

Zitieren

APA

Liang, Y., Li, W., Tan, X., Chen, N., Feng, D., Tao, Y., Wu, X., Liu, L., & Ge, L. (2026). Self-sacrificing templated-derived chitosan microcapsules for targeted drug delivery in thrombolytic therapy. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2026.114751

Vancouver

Liang Y, Li W, Tan X, Chen N, Feng D, Tao Y, et al. Self-sacrificing templated-derived chitosan microcapsules for targeted drug delivery in thrombolytic therapy. Journal of Controlled Release. 2026. doi:10.1016/j.jconrel.2026.114751

BibTeX
@article{Liang2026,
  author = {Liang, Yanling and Li, Weikun and Tan, Xin and Chen, Nuoya and Feng, Diyi and Tao, Yinghua and Wu, Xiaojing and Liu, Ling and Ge, Liqin},
  title = {Self-sacrificing templated-derived chitosan microcapsules for targeted drug delivery in thrombolytic therapy},
  journal = {Journal of Controlled Release},
  year = {2026},
  doi = {10.1016/j.jconrel.2026.114751}
}
Kostenlos starten →